Latest Equity Incentives News

TruScreen Group Limited has announced a placement of over 1.7 million shares to settle marketing invoices and provide an equity incentive to its CFO, signaling strategic capital management ahead of its next growth phase.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

WiseTech Global has appointed Zubin Appoo as its permanent CEO, succeeding interim leader Andrew Cartledge who will retire later this year. Appoo’s deep company roots and broad tech leadership experience position him to steer WiseTech’s next chapter.

Critica Limited has appointed Jacob Deysel as CEO to accelerate development of its Jupiter Rare Earth Project, signalling a strategic shift from exploration to production readiness. Deysel’s extensive global mining experience and rare earths expertise position the company for its next growth phase.

Mandalay Resources Corporation has agreed to a plan of arrangement to be acquired by Alkane Resources Limited through its wholly owned subsidiary. Mandalay shareholders will receive 7.875 Alkane shares for each Mandalay share held, creating a combined gold and antimony producer with a strong balance sheet and diversified operations across Australia and Sweden.

Richmond Vanadium Technology slows key project activities and reshapes its leadership team to navigate a prolonged period of low vanadium prices while advancing battery technology development.

Nanollose Limited has appointed Andrew Moullin as its new CEO and Managing Director, aiming to leverage his extensive commercial expertise to fast-track the company’s microbial cellulose technology towards market readiness.

Yancoal Australia Ltd reported robust 2024 financial results and outlined key corporate governance actions at its 2025 Annual General Meeting, reinforcing its position as a leading coal producer amid market challenges.

Aurum Resources has secured a joint venture to earn up to 80% interest in two new exploration permits adjacent to its 1.6Moz Boundiali Gold Project in Côte d'Ivoire, significantly expanding its landholding and growth potential.

Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

Hearts & Minds Investments Limited is reshaping its leadership by appointing seasoned executive Richard Howes as part-time Managing Director, following operational upgrades under outgoing CEO Brett Jollie.